Advanced Life Sciences Holdings, Inc.

SBIR grant to be used for study of drug for stroke patients

Published in Pharma Investments, Ventures and Law Weekly, March 5th, 2006

Advanced Life Sciences Holdings, Inc., (ADLS) was awarded a phase I Small Business Innovation Research (SBIR) grant to investigate the ability of its small molecule therapeutic, ALS-886, to reduce brain swelling leading to tissue damage following stroke in preclinical testing.

The grant was funded by the National Institute of Neurological Disorders and Stroke and is being conducted in collaboration with scientists at Duke University.

"This SBIR grant helps validate the promise of our early-stage pipeline products," said Michael T. Flavin, PhD, chairman and CEO. "SBIR grant funding is a non-dilutive financing mechanism which has enabled Advanced Life...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly

Source: Pharma Investments, Ventures and Law Weekly (2006-03-05)

More Articles from Pharma Investments, Ventures and Law Weekly

Abiomed, Inc.
Cardiac device maker reports 10% increase in revenue
Access Pharmaceuticals, Inc.
Drug delivery-focused company receives notice of AMEX delisting
Aceto Corp.
Chemically derived drug distributor posts decline in revenue
Adams Respiratory Therapeutics, Inc.
Drug developer focused on respiratory diseases reports 75% increase in sales
Aksys, Ltd.
Dialysis systems maker responds to Nasdaq notification
Akzo Nobel
Pharmaceutical division to be separated from parent company
More from this issue of Pharma Investments, Ventures and Law Weekly

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry